title: Idarubicin plus ARA-C followed by allogeneic or autologous bone marrow transplantation in advanced acute lymphoblastic leukemia.
authors.affiliation: Department of Human Biopathology, University La Sapienza, Rome.
authors.forename: W
authors.initials: W
authors.lastname: Arcese
authors.forename: G
authors.initials: G
authors.lastname: Meloni
authors.forename: F
authors.initials: F
authors.lastname: Giona
authors.forename: M L
authors.initials: ML
authors.lastname: Vegna
authors.forename: A M
authors.initials: AM
authors.lastname: Testi
authors.forename: L
authors.initials: L
authors.lastname: Annino
authors.forename: A P
authors.initials: AP
authors.lastname: Iori
authors.forename: M
authors.initials: M
authors.lastname: Carotenuto
authors.forename: L
authors.initials: L
authors.lastname: Resegotti
authors.forename: E
authors.initials: E
authors.lastname: Madon
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D011446:Prospective Studies; D012074:Remission Induction; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
chemical_list: D003561:Cytarabine; D015255:Idarubicin